phenytoin has been researched along with Neuroleptic Malignant Syndrome in 6 studies
Neuroleptic Malignant Syndrome: A potentially fatal syndrome associated primarily with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS) which are in turn associated with dopaminergic receptor blockade (see RECEPTORS, DOPAMINE) in the BASAL GANGLIA and HYPOTHALAMUS, and sympathetic dysregulation. Clinical features include diffuse MUSCLE RIGIDITY; TREMOR; high FEVER; diaphoresis; labile blood pressure; cognitive dysfunction; and autonomic disturbances. Serum CPK level elevation and a leukocytosis may also be present. (From Adams et al., Principles of Neurology, 6th ed, p1199; Psychiatr Serv 1998 Sep;49(9):1163-72)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 9-year-old girl with akinetic-rigid parkinsonism with tremor is described." | 1.33 | Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child. ( Cantú-Martínez, L; Flores, Lde L; González, HC; Martínez, HR; Onofre-Castillo, J; Villarreal, HJ, 2006) |
| "The case of a young female patient with neuroleptic malignant syndrome (NMS) and extended MRI white matter hyperintensity in the left parietal and both occipital lobes is reported." | 1.28 | MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)--a clue to pathogenesis? ( Becker, T; Beckmann, H; Hofmann, E; Kornhuber, J; Rupprecht, C; Weller, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Whyte, CJ | 1 |
| Rosini, JM | 1 |
| Shin, HW | 1 |
| Youn, YC | 1 |
| Abu-Kishk, I | 1 |
| Toledano, M | 1 |
| Reis, A | 1 |
| Daniel, D | 1 |
| Berkovitch, M | 1 |
| Martínez, HR | 1 |
| Cantú-Martínez, L | 1 |
| González, HC | 1 |
| Flores, Lde L | 1 |
| Villarreal, HJ | 1 |
| Onofre-Castillo, J | 1 |
| Becker, T | 1 |
| Kornhuber, J | 1 |
| Hofmann, E | 1 |
| Weller, M | 1 |
| Rupprecht, C | 1 |
| Beckmann, H | 1 |
| Woolf, DC | 1 |
6 other studies available for phenytoin and Neuroleptic Malignant Syndrome
| Article | Year |
|---|---|
Dantrolene for Treatment of Suspected Neuroleptic Malignant Syndrome.
Topics: Analgesics, Opioid; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Dantrolene; Diagnosis, D | 2018 |
Neuroleptic malignant syndrome induced by phenytoin in a patient with drug-induced Parkinsonism.
Topics: Anticonvulsants; Antipsychotic Agents; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pa | 2014 |
Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic.
Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Blood Cell Count; Child; Dibe | 2004 |
Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child.
Topics: Anticonvulsants; Antiparkinson Agents; Aspartic Acid; Basal Ganglia; Benzothiazoles; Carbamazepine; | 2006 |
MRI white matter hyperintensity in neuroleptic malignant syndrome (NMS)--a clue to pathogenesis?
Topics: Adult; Brain; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Neuroleptic Malig | 1992 |
Neuroleptic malignant syndrome associated with phenytoin intoxication.
Topics: Adult; Humans; Male; Neuroleptic Malignant Syndrome; Phenytoin | 1988 |